Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories shows steady growth
Stay up-to-date with the Dr. Reddy's Laboratories Stock Liveblog, your trusted source for real-time updates and thorough ...
Dr Reddy’s, Hetero ink royalty-free pact with Gilead
Dr Reddy's Laboratories and Hetero sign non-exclusive, royalty-free agreements with Gilead Sciences to manufacture ...
The Financial Express9h
Dr. Reddy’s enters into licensing agreement with Gilead Sciences for HIV drug
Additionally, Lenacapavir is currently under investigation for the prevention of HIV (PrEP) which is yet to be approved ...
Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir
Dr Reddy's Laboratories and Hetero, along with other generic drug makers, enter into voluntary licensing agreements with ...
Pharmabiz9h
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...
Indiatimes15h
Dr. Reddys - Dr. Reddy's Laboratories Share Price
Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 112,608.38 Crore) operating in Pharmaceuticals sector. Dr. Reddy's Laboratories Ltd. key ...